First Cat-Specific Blood Pressure Drug Approved — and the FDA File Shows Why Catching It Late Costs Vision
On April 29, 2026 the FDA approved AMODIP (amlodipine besylate chewable tablets, Ceva) — the first cat-specific drug for systemic hypertension in cats. In the field study systolic pressure fell 28.2 mmHg on average by Day 28. But the same FDA file notes that cats whose vision was already severely lost at treatment start were less likely to regain it even after the retina reattached. Feline hypertension travels with kidney disease and is invisible at home. What to do now.

What Was Approved

midArticleCta.byCategory.news.title
midArticleCta.byCategory.news.description
Meer dan 380.000 katteneigenaren in 50 landen vertrouwen op CatsMe
Feline Hypertension Travels With Kidney Disease — and Shows You Nothing at Home
The Real Story Is One Sentence in the FDA File
Cats that had severe fundic lesions and severely decreased or absent vision at the start of treatment were less likely to regain visual function, despite retinal reattachment and improvement in retinal hemorrhages.
What To Do Now: Start by Asking for the Measurement
Turn Invisible Change Into a Record — CatsMe
Kun je antwoorden op "sinds wanneer is dit aan de gang?"
Als de dierenarts het vraagt, wil je niet met lege handen staan. CatsMe registreert automatisch dagelijkse gezondheidsscores die je met één tik kunt delen.
FAQ

Wees voorbereid op het moment dat je voelt dat er iets niet klopt
Eén foto is genoeg: de AI leest pijn en gezondheid af aan de uitdrukking van je kat. Controleer op het moment dat je twijfelt en deel het logboek met je dierenarts.